When President Trump announced a new deal Friday to lower prescription drug costs, it was the clearest sign yet that he'd paused his commerce secretary's push to slap 100% tariffs on pharmaceuticals that aren't manufactured in the U.S.
Why it matters: Prescription drug policy and tariffs are big priorities of Trump's administration. But after the two issues collided in a conflicting series of White House messages recently, Trump set aside the tariffs idea, which could have made drugs more expensive for many Americans.
